Target intelligence / Profile preview

Nucleophosmin 1 pseudogene 28 (NPM1P28)

Target: NPM1P28
Molecular classification: Other (pseudogene)

Overview

Nucleophosmin 1 pseudogene 28 (NPM1P28) is a member of the NPM1 pseudogene family. Pseudogenes like NPM1P28 are DNA sequences similar to known protein-coding genes but are typically nonfunctional due to the absence of coding potential, regulatory elements, or the presence of disruptive mutations. Unlike functional NPM1, which has key roles in ribosome biogenesis and is mutated in various cancers (notably acute myeloid leukemia[2]), NPM1P28 has no described protein product, biological function, disease association, or use as a drug target or biomarker.

Beyond the preview

Go deeper on Nucleophosmin 1 pseudogene 28 (NPM1P28).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleophosmin 1 pseudogene 28 (NPM1P28).

Explore the full profile